Loading...

Financial Summary


GTx Inc.

GTx Inc. (GTXI)

Healthcare
Neutral
B+
Market Info
Financial Info
Financial Modelling
Symbol GTXI
Price 1.28$
Beta 2.57
Volume Avrg. 0.12M
Market Cap 0.03B
Shares (2018) 23,346.23K
Last Div 0
Dividend Yield -
DCF Unlevered -
DCF Levered -
ROE -147.13% Strong Sell
ROA -147.66% Strong Sell
Operating Margin -Infinity% Strong Sell
Debt / Equity 0.00% Neutral
P/E - Neutral
P/B 0.72 Buy

Income Statement

Download GTXI income statement Download GTXI income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Earnings Per Share Basic -12.703.90--0.43-0.67-0.48-0.13-1.22-1.75-1.65
Net Profit Margin -3.140.27--------
Earnings Per Share Diluted -12.703.90--0.43-0.67-0.48-0.15-1.22-1.75-1.65
Revenue 14.7356.79--------
Weighted Average Shares Outstanding 3.643.89-62.8163.0681.81140.3614.5617.4423.35
Gross Profit 13.4456.79--------
Weighted Average Shares Outstanding (Diluted) 3.643.89-62.8163.0681.81140.3614.5617.4423.35
Sales, General and Administrative Expense 27.7813.19-10.8511.289.488.238.719.199.39
Dividend per Share ----------
Operating Income -46.6815.10--49.73-43.60-30.35-21.84-25.93-30.66-39.06
Gross Margin 0.911.00--------
Earnings before Tax -46.4915.29--35.90-42.11-39.41-18.70-17.72-30.44-38.42
EBITDA Margin ----------
Net Income -46.2615.29--27.07-42.11-39.41-18.70-17.72-30.44-38.42
EBIT Margin -3.160.27--------
Net Income - Discounted ops ----------
Profit Margin ----------
Preferred Dividends ----------
Free Cash Flow margin -0.00-0.00--------
R&D Expenses 32.3428.50-38.8932.3220.8713.6117.2321.4729.67
Interest Expense ----8.82------
Earnings Before Tax Margin -3.160.27--------
Consolidated Income -46.2615.29--27.07-42.11-39.41-18.70-17.72-30.44-38.42
EBIT -46.4915.29--49.73-43.60-30.35-21.84-25.93-30.66-39.06
EBITDA -44.7116.87--48.98-43.22-30.25-21.80-25.91-30.61-39.01
Income Tax Expense -0.24---8.82------
Operating Expenses 60.1241.69-49.7343.6030.3521.8425.9330.6639.06
Cost of Revenue 1.29---------
Net Income Com -46.2615.29--27.07-42.11-39.41-18.70-17.72-30.44-38.42
Net Income - Non-Controlling int ----------

Balance Sheet Statement

Download GTXI income statement Download GTXI income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total current liabilities 15.955.30-9.494.5732.7930.174.617.975.21
Other Liabilities 14.684.46--------
Long-term debt ----------
Cash and cash equivalents 40.2258.18-48.0414.5317.8814.068.9115.8228.26
Total debt ----------
Cash and short-term investments 49.0458.63-56.0914.7349.3029.2621.8743.9028.46
Deferred revenue 59.858.07--------
Inventories 0.120.17--------
Tax Liabilities ----------
Goodwill and Intangible Assets 3.751.85-----0.120.110.09
Deposit Liabilities ----------
Tax assets ----------
Total non-current liabilities 50.527.22-0.580.350.03----
Total current assets 7.053.89-56.8115.1750.1531.8924.3046.0831.21
Total liabilities 66.4712.52-10.074.9232.8230.174.617.975.21
Payables 1.270.85-1.710.810.510.381.222.603.28
Other comprehensive income ---460.89465.98512.46515.19551.07599.88626.14
Short-term investments 8.820.45-8.040.2031.4115.2012.9628.080.20
Retained earnings (deficit) -368.17-352.88--413.25-455.36-494.77-513.47-531.20-561.64-600.05
Property, Plant & Equipment Net 3.292.04-0.510.110.030.010.080.050.02
Total non-current assets 50.527.22-0.960.430.500.140.200.160.11
Other Assets 0.920.88--------
Net Debt -49.04-58.63--48.04-14.53-17.88-14.06-8.91-15.82-28.26
Investments 8.820.45-8.040.2031.4115.2012.9628.080.20
Total shareholders equity -8.7551.73-47.7010.6817.831.8619.8938.2626.11
Total assets 57.7264.25-57.7715.6150.6532.0324.5046.2431.32
Long-term investments ----------
Receivables 0.590.68-0.01------
Short-term debt ----------

Cash Flow Statement

Download GTXI income statement Download GTXI income statement
Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Insurance (repayment) of debt ----------
Net Cash/Marketcap 0.000.00--------
Insurance (buybacks) of shares ----------
Depreciation & Amortization 1.781.57-0.750.380.100.040.030.050.05
Dividend payments ----------
Operating Cash Flow -46.00-30.53--37.11-43.97-28.76-20.04-20.78-23.46-39.35
Acquisitions and disposals ----------
Free Cash Flow -46.60-30.62--37.25-44.00-28.76-20.04-20.87-23.46-39.35
Net cash flow / Change in cash -55.2917.96--15.70-33.523.35-3.82-5.156.9128.26
Effect of forex changes on cash ----------
Financing Cash Flow 0.1340.21-0.001.2263.33-13.4845.4923.91
Investment purchases and sales -8.828.38--------
Capital Expenditure -0.60-0.10-0.140.030.010.000.090.00-
Stock-based compensation 5.174.70-2.653.734.432.622.963.152.20
Investing Cash Flow ----------

Retained Earning Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Retained Earnings (Previous Year) --368-353--413-455-495-513-531-562
Net Income -4615--27-42-39-19-18-30-38
Stock Dividends -322-353-386------
Divident Paid ----------
Retained Earnings -368-353--413-455-495-513-531-562-600

PPE Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Year 2009201020112012201320142015201620172018
Gross PPE -32-100000
Annual Depreciation 4-1-20-0-0-0-0-0-0
Capital Expenditure -1-0-000000-
Net PPE 32-1000000

Intangible and Goodwill Schedule

Year 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Intangible and Goodwill (Previous Year) -42-----00
New Purchases -98--------
Intangible and Goodwill 42-----000
GTx Inc.

GTx Inc. (GTXI)

1.28
-0.01 (-0.39%)

About


Marc S. Hanover
Healthcare
Biotechnology
NASDAQ Capital Market

GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.